T1	Participants 130 188	58 infants and children with the hemolytic-uremic syndrome
T2	Participants 464 481	group of patients
T3	Participants 704 714	two groups
T4	Participants 879 891	both groups.
T5	Participants 322 334	two patients
T6	Participants 305 321	treatment group,
T7	Participants 634 648	treated group.
